Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives

Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2) Synthesis and primary evaluation of quinoxalinone derivatives as potent modulators of multidrug resistance Design and synthesis of new potent N,N -bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents Isomeric N,N-Bis(cyclohexanol)amine Aryl Esters:  The Discovery of a New Class of Highly Potent P-Glycoprotein (Pgp)-dependent Multidrug Resistance (MDR) Inhibitors Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance Structure−Activity Relationships Studies in a Series of N,N-Bis(alkanol)amine Aryl Esters as P-Glycoprotein (Pgp) Dependent Multidrug Resistance (MDR) Inhibitors New Potent P-Glycoprotein Inhibitors Carrying a Polycyclic Scaffold Synthesis and Biological Evaluation of (Hetero)Arylmethyloxy- and Arylmethylamine-phenyl Derivatives as Potent P-glycoprotein Modulating Agents Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators